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The aim of the study was to prepare berberine hydrochloride long-circulating liposomes and
optimize the formulation and process parameters, and investigate the influence of different
factors on the encapsulation efficiency. Berberine hydrochloride liposomes were prepared in
response to a transmembrane ion gradient thatwas establishedby ionophoreA23187. Freeand
liposomal drug were separated by cation exchange resin, and then the amount of intra-
liposomal berberine hydrochloride was determined by UV spectrophotometry. The optimized
encapsulation efficiency of berberine hydrochloride liposomes was 94.3%  2.1% when the
drug-to-lipid ratio was 1:20, and the mean diameter was 146.9 nm  3.2 nm. As a result, the
ionophore A23187-mediated ZnSO4 gradient method was suitable for the preparation of
berberine hydrochloride liposomes that we could get the desired encapsulation efficiency and
drug loading.
ª 2013 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction et al. [5] found that in varying degrees, Ber could inhibit theBerberine hydrochloride (Ber) is a quaternary ammonium
salt from the group of isoquinoline alkaloids, which has
been proved for various pharmacological actions [1], and it
is usually used for the treatment of the intestinal infection
in clinical. In addition, recent research found that Ber has
many new pharmacological actions, such as the treatment
of arrhythmia [2], hyperlipidemia [3], and diabetes [4]. Yang, þ86 13304054030 (mobil
g Pharmaceutical Univer
sevier
ang Pharmaceutical Univgrowth of cervical cancer cell lines (U14), sarcoma cell lines
(S180), and hepatoma cell lines (H22) in mice, and induct the
tumor cell differentiation and apoptosis. However, Huang
et al. [6] found that Ber had no significant anti-tumor effect
in vivo comparing to the in vitro experiments, the cause
was that Ber was difficult to afford enough drug concen-
tration in plasma, which could not deliver drug effectively
to tumor cells lead to Ber difficult to achieve effective druge); fax: þ86 24 23986316.
sity
ersity. Production and hosting by Elsevier B.V. All rights reserved.
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Ber might cause side effects such as eruption, allergic re-
actions when it was administered directly though intrave-
nous injection. Moreover, the use of berberine hydro
chloride solution directly through intravenous has been
banned in China since 1982 [7].
In this study, we presume that Ber is loaded into stealth
liposomes with long-circulating and the enhanced perme-
ability and retention (EPR) effect, decreasing Ber adverse
reactions and improving its targeting of tumor tissue [8].
Currently, the encapsulation efficiency of Ber liposomes
(Ber-L) prepared by passive loading method is lower than by
active loading method, and our research group has reported
using a transmembrane pH gradient to prepare Ber-L with
encapsulation efficiency up to 84.6% [9], but the method
requires adjusting the pH value outside the liposomes to
form a sufficient transmembrane pH gradient when it does
not conducive to the stability of the liposomes.
Therefore, we chose the ionophore A23187-mediated to
establish transmembrane ion gradient, which was a relatively
mild ZnSO4 gradientmethod.We employed the encapsulation
efficiency as an indicator to optimize the formulation. There
have been no reports on the method of preparation of
berberine hydrochloride liposomes recently.2. Materials and methods
2.1. Materials
Berberine hydrochloride (Ber, >98%) was purchased from
Liaoning Shenyang Northeast General Pharmaceutical Factory
(China). Hydrogenated soybean phospholipids (HSPC) were ob-
tained fromLucasMeyerCo. Ltd. (Du¨sseldorf, German). Soybean
phospholipids (SPC) and egg yolk lecithin (EPC) were supported
from Lipoid Co. Ltd. (German). Cholesterol (CH) was supplied by
Nanjing Xinbai Pharmaceutical Co. Ltd. (China). Methoxy (poly-
ethylene glycol)2000-cholesteryl succinate (mPEG2000-CHEMS)
was synthesized in our laboratory. Ammonium sulfate was
provided by Shenyang Chemical Reagent Factory Ltd. (China).
Anion and cation exchange resins were purchased from
Shanghai Sinopharm Chemical Reagent Co. Ltd. (China). All
other chemicals were of analytical grade.
2.2. Preparation of Ber-L
2.2.1. Preparation of Ber solution
0.0150 g of Ber bulk drugwas preciselyweighed and dissolved in
5 ml redistilled water, shaken up evenly, obtained Ber solution
(3 g/l).
2.2.2. Preparation of hydration medium
0.4313 g of ZnSO4$7H2O was precisely weighed and dissolved
in 5 ml redistilled water, shaken up evenly, filtered through a
0.22 mmpore sizeMillipore filter, then obtained ZnSO4 solution
(300 mmol/l).
2.2.3. Preparation of sucrose solution
10.2690 g of sucrose was precisely weighed and dissolved in
100 ml redistilled water, shaken up evenly, filtered through a0.22 mm pore size Millipore filter, finally obtained sucrose solu-
tion (300mmol/l).
2.2.4. Preparation of ionophore A23187 solution
0.0010 g of ionophore A23187 was precisely weighed and dis-
solved in 1ml dehydrated alcohol, shaken up evenly, obtained
A23187 solution (1.0 g/l).
2.2.5. Preparation of EDTA-2Na solution
0.5584 g of EDTA-2Na was precisely weighed and dissolved in
100 ml redistilled water, shaken up evenly, filtered through a
0.22 mm pore size Millipore filter, finally obtained EDTA-2Na
solution (150 mmol/l).
2.2.6. Preparation of empty liposomes
Liposomes were prepared by a modified ethanol injection
method. Briefly, a lipid mixture containing HSPC/CH/mPEG2000-
CHEMS (3/1/0.04, wt/wt/wt) was dissolved in 0.4 ml of dehy-
drated alcohol, added 4 ml of preheating hydration medium
when all constituents were dissolved, incubated for 20 min at
65 C with stirring, achieved primary empty liposomes. To
reduce primary empty liposomes size, the resulting vesicles
were sonicated using a JY92-2D Vibra-cell probe sonicator
(Ningbo Xinzhi Biological Technology Co. Ltd. China) equipped
with a tapered tip, for 2-min cycle (200 W) and an additional 4-
min cycle (400 W). The suspensions were then filtered through
0.8 and 0.45 mmpore sizeMillipore filter three times respectively
to remove large particles. Eventually the empty liposomes were
prepared and the final phospholipids concentration was 50 g/l.
The mean diameters and Zeta potential of the liposomes were
determined in purified water at 23 C using a NICOMP 380 HPL
submicron particle analyzer (Particle Sizing System, CA, USA)
operating at 632.8 nm.
2.2.7. Constructing transmembrane ionic gradient with anion
and cation mixed fiber column
Add 0.3 ml of empty liposomes to the pretreated mixed fiber
column, equilibrate for 5 min and then centrifugate at 2000 r/
min for 4 min. Liposomes with transmembrane ionic gradient
(gradient liposomes) were obtained [10].
2.2.8. Drug loading of empty liposomes
Dilute empty liposomes to 0.75 ml with 300 mmol/l sucrose so-
lution, add 0.2ml of 150mmol/l EDTA-2Na solution and A23187
solution, add Ber solution after incubating for 10 min in water
bathat 60 C, continue to incubate for 120min, stop loadingdrug
with ice water bath, finally, obtained Ber-L. In the following ex-
periments, we will change the condition respectively to study
the influencing factors on encapsulation efficiency.
2.3. Determination of the encapsulation efficiency
Add 1.2 ml of 300 mmol/l sucrose solution into 0.1 ml empty
liposomes and blend well, dilute to 10 ml with isopropanol in
volume fraction of 90% (containing 0.75 mol/l HCl), shake up
evenly. The absorbance at wavelength of 350 nm was indi-
cated as A0. Another 0.1 ml empty liposomes were overlaid on
top of a cation exchange resin micro-column, centrifugated at
2000 r/min for 4 min, added 0.4 ml of 300 mmol/l sucrose so-
lution on top of the micro-column to elute the liposomes,
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and centrifugation were repeated two times. Sequentially, the
eluant was diluted to 10 ml with isopropanol in volume frac-
tion of 90% (containing 0.75 mol/l HCl). The absorbance at
350 nm was denoted as A1. The encapsulation efficiency was
calculated via formula: EE% ¼ ðA0=A1Þ  100% (EE stands for
encapsulation efficiency).Fig. 2 e Effect of different hydration mediums on the drug
loading efficiency (n [ 3).2.4. The research of influencing factors on encapsulation
efficiency
2.4.1. Effect of different hydration mediums on encapsulation
efficiency
As is in Fig. 2, the hydration medium had significantly effect
on the drug uptake and the encapsulation efficiency achieved
when employing the ZnSO4 as the hydration medium to pre-
pare the liposomes is apparently higher than the
MgSO4$FeCl2$Ca(Ac)2 and Cu(Ac)2. Thus, the following prepa-
ration utilizes the ZnSO4 as the hydration medium.
2.4.2. Effect of the concentration of ZnSO4 solution on drug
encapsulation
As is in Fig. 3, when the concentration of ZnSO4 solution was
300mmol/l, the amount of drug loaded into the liposomeswas
the largest. As a result, 300 mmol/l ZnSO4 solution was
regarded as the optimal concentration.
2.4.3. Effect of different phospholipids on encapsulation
efficiency
As can be seen in Fig. 4, the maximum encapsulation effi-
ciency was obtained when choosing the HSPC to prepare the
liposomes. Furthermore, HSPC, which is hydrogenated soy-
bean lecithin, is more stable than the nature lecithin. There-
fore, HSPC was chosen as membrane material to prepare the
liposomes in this study taking everything into consideration.
2.4.4. Effect of incubation temperature on Ber encapsulation
As depicted in Fig. 5, the maximum encapsulation effi-
ciency was achieved at 60 C and this loading course wasFig. 1 e The mechanism of A23187-mediated establishing
a transmembrane pH gradient.found temperature-dependent. However, the encapsulation
when the temperature was >60 C efficiency decreased.
This may be due to the higher permeability of the bilayer
and the faster drug molecular motion at a higher tempera
ture.
2.4.5. Effect of incubation time on uptaking efficiency
When the time was 120 min, the encapsulation efficiency of
liposomes increased, however, when the time was >120 min,
the amount of leakage is more than loading, so the encapsu-
lation efficiency decreased (in Fig. 6).
2.4.6. Effect of A23187/HSPC ratios on loading efficiency
As shown in Fig. 7, because when the A23187/HSPC ratios was
1 mg/mg, the drug loaded into the liposomes ismaximum, sowe
employed the 1 mg/mg A23187/HSPC ratios to prepare the
liposomes.Fig. 3 e Effect of different ZnSO4 concentrations on the drug
loading efficiency (n [ 3).
Fig. 4 e Effect of different phospholipids on the drug
loading efficiency (n [ 3).
Fig. 6 e Effect of incubation temperature on the drug
loading efficiency (n [ 3).
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As demonstrated in Fig. 8, the encapsulation efficiency de-
creases with the increase drug/lipid ratios, as the result, in
this study the drug/lipid ratios we employed is 1:20.
2.4.8. Effect of different mPEG2000-CHEMS amounts on
encapsulation efficiency
As illustrated in Fig. 9, when the ratio of m (HSPC):m (CH):m
(mPEG2000-CHEMS) was 3/1/0.04 (wt/wt/wt), the encapsulation
efficiency achieved was close to the ratio of which was 3/1/0.75
(wt/wt/wt), however, the larger of the ratio ofmPEG2000-CHEMS,
themore stable of the liposomes, consequently, the drugwhich
loaded into the liposomes was not easy to leak. Considering
abovefactors, theratioofm(HSPC):m(CH):m (mPEG2000-CHEMS)
we chose is 3/1/0.75 (wt/wt/wt) in this study.
2.4.9. Effect of different gradient liposomes concentrations of
encapsulation efficiency
As revealed in Fig. 10, when the concentration of gradient li-
posomes was50 g/l, the concentration of gradient liposomesFig. 5 e Effect of incubation temperature on the drug
loading efficiency (n [ 3).had little effect on the encapsulation efficiency. In addition,
when employing the high concentration of gradient lipo-
somes, the amount of the drug loaded into the liposomes
increased. In conclusion, 50 g/l is the optimum concentration
of the gradient liposomes.3. Results and discussion
3.1. The optimum formulation and technology
As a consequence, we choose a concentration of 300 mmol/l
ZnSO4 solution as the hydration medium, HSPC as the base-
ment of membrane material, 1 mg/mg as A23187/HSPC ratios,
1:20 as drug/lipid ratios (wt/wt), HSPC/CH/mPEG2000-CHEMS
(3/1/0.75, wt/wt/wt) is the optimal lipid formulation, and
50 g/l as gradient liposomes concentration incubated the Ber-L
at 60 C for 120 min. The encapsulation efficiency of theFig. 7 e Effect of A23187/HSPC ratio on the drug loading
efficiency (n [ 3).
Fig. 8 e Effect of drug/lipid ratios on the drug loading
efficiency (n [ 3).
Fig. 10 e Effect of different gradient liposomes
concentrations of encapsulation efficiency of HSPC/CH/
mPEG2000-CHEMS (3/1/0.75, wt/wt/wt) liposomes (n [ 3).
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146.9 nm  4.5 nm (in Fig. 11), and the Zeta potential is
24.40 mV  2.5 mV (in Fig. 12).3.2. The advantage of A23187 creating a
transmembrane gradient
When gradient liposomes were incubated with Ber solution at
60 C, we could find that it needs a long time (120 min) to
achieve successful drug loading (90.5%), which was distin-
guished from general pH gradient method and (NH4)2SO4
gradient method. It was shown that by the way of using
A23187 to create a transmembrane gradient was relatively
slow, as well as pH value changes was not dramatic on both
sides of the bilayer membrane, which could avoid phospho-
lipid to be degraded and improve the formulation stability. As
the Ber loading into the gradient liposomes, the gradient isFig. 9 e Effect of different mPEG2000-CHEMS amounts on the
drug loading efficiency (n [ 3).gradually consumed. Unlike traditional pH gradient method,
A23187 will continue to work and maintain the trans-
membrane ion gradient. It was a significant advantage that
the ionophore A23187-mediated established transmembrane
ion gradients.3.3. The probable mechanism of berberine retained
interliposome
It was observed that when cation exchange fiber could only be
used to remove Zn2þ in external water phase and to form the
gradient liposomes, which is much lower encapsulation effi-
ciency than used mixed ion exchange fibers. Interestingly,
when the hydration mediums composed of 200 mmol/l
(NH4)2SO4 and 300 mmol/l ZnSO4 (not plus A23187), and only
removed cation in external aqueous phase of liposomal sus-
pension, the encapsulation efficiency of preparation (data not
shown) was far lower than that of hydration medium con-
taining either 300 mmol/l ZnSO4 or 200 mmol/l (NH4)2SO4.Fig. 11 e Particle size and size distribution of the prepared
Ber-L.
Fig. 12 e Zeta potential of the prepared Ber-L.
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we used (NH4)2SO4 to establish the gradient, the SO4
2was only
existing in the internal aqueous phase of liposomes so that the
berberine which was loaded in internal aqueous phase would
form berberine sulfate with SO4
2. It was observed that SO4
2
had a negative effect on the process of drug loading into li-
posomes. Probably, the solubility of berberine sulfate was
greater than berberine hydrochloride in water, thus inducing
drug less trend to be retained interliposome.
3.4. The mechanism of A23187-mediated establishing a
transmembrane pH gradient
A23187 was a divalent metal ion transporter and movable
ionophore, which could selectively catalytic divalent metal
ion (Zn2þ, Ca2þ, Mg2þ etc.) exchange into protons [11]. In detail,
A23187 coupled the external transport of one Zn2þ ion (down
its concentration gradient) to the internal transport of two
protons. This process resulted in acidification of the internal
aqueous phase, creating a pH gradient. The external drug
existed in neutral and protonated forms, and the former could
diffuse across the membrane (down its concentration
gradient). Once into the liposomes, they were protonated and
trapped, resulting in an extremely low internal concentration
of neutral drug, which therefore continued to drive uptake. In
order for this process to occur, EDTA as an external chelator
was required to bind Zn2þ ions when they were transported
out of the liposomes, thereby maintaining a sufficient
gradient of the free ion [12]. So we used the A23187-mediated
in establishing a transmembrane pH gradient directly, and
then the Ber was loaded into liposomes (Fig. 1).4. Conclusion
In the present study, a novel Ber-L with high encapsulation
efficiency was developed by ZnSO4 gradient. Encapsulationefficiency was determined rapidly and accurately using mix-
ion exchange fiber separation-ultraviolet spectrophotometry.
The research proposed that the ionophore A23187-mediated
ZnSO4 gradient method resulted in a high encapsulation effi-
ciency of Ber-L that was 94.3%  2.1%. Although it was
demonstrated that the method to establish the gradient was
relatively slow, the loss of gradient was more difficult
compared with the conventional pH gradient, thus achieving
higher encapsulation efficiency and more stable liposomes.
The gradient liposomes established method can provide a
certain value for the development of Ber-L and a new
approach for the liposomal preparation of similar drugs in this
article.r e f e r e n c e s
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